Whole-body MRI and PET-CT in the management of cancer patients

European Radiology

Volumn 16, Issue 6, 2006, Pages 1216-1225

  Schmidt, Gerwin P ^a   Haug, Alexander R ^a   Schoenberg, Stefan O ^a   Reiser, Maximilian F ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Computed tomography; Magnetic resonance imaging; Oncology; Positron emission tomography; Screening

Indexed keywords

FLUORODEOXYGLUCOSE F 18; TECHNETIUM 99M;

ARTICLE; BONE SCINTISCANNING; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; COMPUTER PROGRAM; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; HUMAN; IONIZING RADIATION; LIVER METASTASIS; LUNG METASTASIS; MALIGNANT NEOPLASTIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGICAL ANATOMY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; TREATMENT OUTCOME; VISCERAL METASTASIS;

EARLY DIAGNOSIS; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE ENHANCEMENT; IMAGE PROCESSING, COMPUTER-ASSISTED; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MASS SCREENING; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RADIATION DOSAGE; RADIOPHARMACEUTICALS; TOMOGRAPHY, SPIRAL COMPUTED; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; WHOLE BODY IMAGING;

EID: 33744790637     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-006-0183-8     Document Type: Article

References (43)

1. World Health Organization (2004) WHO health report 2004: Statistical annex. http://www.who.int. World Health Organization, Geneva, Switzerland
2. Bayes T (1763) An essay towards solving a problem in the doctrine of chances. Philos Trans R Soc Lond 53:370-418
3. Beyer T, Townsend DW, Brun T, Kinahan PE, Charron M, Roddy R et al (2000) A combined PET/CT scanner for clinical oncology. J Nucl Med 41:1369-13679
4. Pelosi E, Messa C, Sironi S, Picchio M, Landoni C, Bettinardi V et al (2004) Value of integrated PET/CT for lesion localisation in cancer patients: A comparative study. Eur J Nucl Med Mol Imaging 31:932-939
5. Lardinois D, Weder W, Hany TF, Kamel EM, Korom S et al (2003) Staging of non-small-cell cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 348:2500-2507
6. Cohade C, Osman M, Leal J, Wahl RL (2003) Direct comparison of 18F-FDG-PET and PET-CT in patients with colorectal carcinoma. J Nucl Med 44:1797-1803
7. Wechalekar K, Sharma B, Cook G (2005) PET/CT in oncology-a major advance. Clin Radiol 60:1143-1155
8. Barkhausen J, Quick HH, Lauenstein T et al (2001) Whole-body MR imaging in 30 seconds with real-time true FISP and a continously rolling table platform: Feasability study. Radiology 220:252-256
9. Pruessmann KP, Weiger M, Scheidegger MB et al (1999) SENSE: Sensitivity encoding for fast MRI. Magn Reson Med 42:952-962
10. Griswold MA, Jakob PM, Heidemann RM et al (2002) Generalized autocalibrating partially parallel acquisitions (GRAPPA). Magn Reson Med 47:1202-1210
11. Roemer PB, Edelstein WA, Hayes CE, Souza SP, Mueller OM (1990) The NMR phased array. Magn Reson Med 16:192-225
12. Keupp J, Aldefeld B, Bornert P (2005) Continously moving table SENSE imaging. Magn Reson Med 53:217-220
13. Anonymous (2004) Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO). http://www3.cancer.gov/prevention/plco
14. Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M et al (2005) Effect of screening and adjuvant therapy on mortality from breast cancer. New Eng J Med 27:1784-1792
15. Nicholson FB, Barro JL, Bartram CI, Dehmeshki J, Halligan S, Taylor S, Kamm MA et al (2005) The role of CT colonography in colorectal cancer screening. Am J Gastroenterol 100:2315-2323
16. Diederich S, Wormanns D, Semik M, Thomas M, Lenzen, Roos N et al (2002) Screening for early lung cancer with low-dose spiral CT: Prevalence in 817 asymptomatic smokers. Radiology:773-778
17. European Comission on Energy (2004) Europe. http://europa.eu.int/comm/erergy/nuclear/radioprotection/doc/legislation/ 9743_en.pdf; accessed November 22
18. Brix G, Lechel U, Glatting G, Ziegler SI, Münzing W, Müller SP, Beyer T (2005) Radiation exposure of patients undergoing whole-body dual-modality 18F-FDG PET/CT examinations. J Nucl Med 46:608-613
19. Goehde SC, Hunold P, Vogt FM, Ajaj W, Goyen M, Herborn CU et al (2005) Full-body cardiovascular and tumor MRI for early detection of disease: feasibility and initial experience in 298 subjects. Am J Roentgenol 184:598-611
20. Kramer H, Schoenberg SO, Nikolaou K, Huber A, Struwe A, Winnik E (2005) Cardiovascular screening with parallel imaging techniques and a whole-body imager. Radiology 236:300-310
21. Ajaj W, Pelster G, Treichel U, Vogt FM, Debatin JF, Ruehm SG (2003) Dark lumen magnetic resonance colonography: Comparison with conventional colonoscopy fort he detection of colorectal pathology. Gut 52:1738-1743
22. American Joint Committee on Cancer (2002) AJCC cancer staging manual, 6th edn. Springer, Berlin Heidelberg New York
23. Antoch G, Saoudi N, Kuehl H, Dahmen G, Mueller SP, Beyer T et al (2004) Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET. J Clin Oncol 22:4357-4368
24. Semelka RC, Worawattanakul S, Kelekis NL et al (1997) Liver lesion detection, characterization, and effect on patient management: comparison of single phase spiral-CT and current MR techniques. J Magn Reson Imaging 7:1040-1047
25. Steinborn M, Heuck AF, Tiling R, Bruegel M, Gauger L, Reiser MF (1999) Whole body bone marrow MRI in patients with metastatic disease to the skeletal system. J Comput Assist Tomogr 23:123-129
26. Antoch G, Vogt FM, Freudenberg LS, Nazaradeh F, Goehde SC, Barkhausen J et al (2003) Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology. JAMA 290:3199-3206
27. Schmidt GP, Baur-Melnyk A, Herzog P, Schmid R, Tiling R, Reiser MF et al (2005) High-resolution whole-body MRI tumor staging with the use of parallel imaging versus dual modality PET-CT: Experience on a 32-channel system. Invest Radiol 40:743-7531
28. Antoch G, Saoudi N, Kuehl H, Dahmen G, Mueller SP, Beyer T et al (2004) Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET. J Clin Oncol 22:4357-4368
29. Gutzeit A, Antoch G, Kühl H, Egelhof T, Fischer M, Hauth E et al (2005) Unknown primary tumours: Detection with dual-modality PET-CT-initial experience. Radiology 234:227-234
30. Brennan DD, Gleeson T, Coate LE, Cronin C, Carney D, Eustace SJ (2005) A comparison of whole-body MRI and CT for the staging of lymphoma. Am J Roentgenol 185:711-716
31. Kellenberger CJ, Miller SF, Khan M, Gilday D, Weitzman S, Babyn PS (2004) Initial experience with FSE STIR-whole-body MR imaging for staging lymphoma in children. Eur Radiol 14:1829-1841
32. Pieterman RM, van Putten JW, Meuzelaar JJ, Mooyaart EL, Vaalburg W, Kotere GH et al (2000) Preoperative staging of non-small-cell lung cancer with positron-emission tomography. N Engl J Med 343:254-261
33. Takahara T, Imay Y, Yamashita T, Yasuda S, Nasu S, Van Cauteren M (2004) Diffusion weighted whole body imaging with background body signal suppression (DWIBS): Technical improvement using free breathing, STIR and high resolution 3D display. Radiat Med 22:275-282
34. Ohno Y, Hatabu H, Takenaka D, Higashino T, Watanabe H, Ohbayashi C et al (2004) Metastases in mediastinal and hilar lymph nodes in patients with non-small cell lung cancer: Quantitative and qualitative assessment with STIR turbo spin-echo MR imaging. Radiology 231:872-879
35. Ghanem N, Uhl M, Brink I, Schäfer O, Kelly T, Moser E (2005) Diagnostic value of MRI in comparison to scintigraphy, PET, MS-CT and PET-CT for the detection of metastases of bone. Eur J Radiol 55:41-55
36. Mentzel HJ, Kentouche K, Sauner D, Fleischmann C, Vogt S, Gottschild D (2004) Comparison of whole-body STIR-MRI and 99m-Tc-methylene-diphosphonate scintigraphy in children with suspected multifocal bone lesions. Eur Radiol 14:2297-2302
37. Schmidt GP, Schoenberg SO, Reiser MF, Baur-Melnyk A (2005) Whole-body MR imaging of bone marrow. Eur J Radiol 55:33-40
38. Daldrup-Link HE, Franzius C, Link TM et al (2001) Whole-body MR imaging for detection of bone metastases in children and young adults: comparison with skeletal scintigraphy and FDG PET. AJR Am J Roentgenol 177:229-236
39. Schlemmer HP, Schäfer J, Pfannenberg C, Radny P, Korchidi S, Müller-Horvat C (2005) Fast whole-body assessment of metastatic disease using a novel magnetic resonance imaging system: Initial experiences. Invest Radiol 40:64-71
40. Cook GJ, Wegner E, Fogleman I (2004) Pitfalls and artefacts in 18 FDG-PET and PET-CT oncologic imaging. Semin Nucl Med 34:122-133
41. Goerres GW, Kamel E, Heidelberg TN, Schwitter MR, Burger C, von Schuthess GK (2002) Accuracy of image co-registration in the thorax: influence of respiration. Eur J Nucl Med Mol Imaging 29:351-360
42. Antoch G, Freudenberg LS, Stattaus J, Jentzen W, Debatin JF et al (2002) Focal tracer uptake: A potential artefact in contrast-enhanced dual-modality PET-CT scans. J Nucl Med 43:1339-1342
43. Ichikawa T, Erturk S, Motosuqi U, Sano K, Ros P et al (2005) Virtual PET-MRI as a novel oncologic imaging of the body: Principles, techniques and clinical applications. RSNA 2005, abstract 1330BP-e